IBM Gains 12% After $1B U.S. Grant and $1B Anderon Quantum Investment
The US government is awarding $1 billion to IBM to establish a quantum-computing chip foundry in Albany, New York. IBM is investing $1 billion in its new Anderon business for processor production, driving a 12% surge in its share price on funding linked to the 2022 Chips and Science Act.
1. Government Funding Awarded
The Commerce Department has committed $1 billion to IBM for a quantum-computing chip foundry in Albany, New York, marking one of the largest federal investments in emerging computing hardware under the 2022 Chips and Science Act.
2. IBM Anderon Investment
IBM plans to allocate an additional $1 billion to its newly formed Anderon business, which will focus on manufacturing quantum processors at the Albany wafer facility alongside government-funded operations.
3. Stock Market Reaction
Following news of the combined $2 billion funding package, IBM shares climbed 12% in a single session, representing the largest one-day gain in over a year and reflecting investor enthusiasm for quantum computing initiatives.
4. Strategic Outlook
The dual funding boost positions IBM to accelerate its leadership in quantum hardware, potentially unlocking new revenue streams from processor sales and bolstering long-term competitive advantage in a nascent but strategically critical technology sector.